MedPath

BLACKMORES EXECUTIVE B TABLET

Registration Number: MAL19991178XCR

Approved
Approval ID

4e2cd5de0fc6ae2e

Registration Number

MAL19991178XCR

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

30Tablet TabletsAvailable
Package Size: 30Tablet Tablets
Status: NPRA Approved
60Tablet TabletsAvailable
Package Size: 60Tablet Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
100 TabletsAvailable
Package Size: 100 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
150 TabletsAvailable
Package Size: 150 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (12)

PYRIDOXINE HCL/VITAMIN B6Active
Monograph: pyridoxine hcl/vitamin b 6
NiacinamideActive
Monograph: 烟酰胺
Potassium sulphateActive
ASCORBIC ACIDActive
Monograph: 维生素C
Folic AcidActive
Monograph: 叶酸
Calcium PantothenateActive
Monograph: 泛酸钙
ZINC SULFATE MONOHYDRATEActive
Monograph: zinc sulfate monohydrate
CYANOCOBALAMINActive
Monograph: 维生素B12
THIAMINE NITRATEActive
Monograph: 硝酸硫胺
BiotinActive
Monograph: Biotin
RIBOFLAVINEActive
Monograph: 维生素B2
Magnesium PhosphateActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BLACKMORES EXECUTIVE B TABLET - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform